Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableNot Yet RecruitingNCT07487571
What this trial is testing

MPV as a Predictor for ACS in Patients With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseAcute Coronary Syndromes (ACS)
Sohag University 60
Not applicableNot Yet RecruitingNCT07585526
What this trial is testing

Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.

Who this might be right for
MASLDChronic Kidney Diseases
Institute of Liver and Biliary Sciences, India 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980
What this trial is testing

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more
Eva Cubric
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Post-approval studies (Phase 4)Looking for participantsNCT07058155
What this trial is testing

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Who this might be right for
Liver CirrhosesPortal Hypertension Related to CirrhosisSevere Obesity+1 more
The Cleveland Clinic 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Testing effectiveness (Phase 2)Looking for participantsNCT05519475
What this trial is testing

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Who this might be right for
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Regeneron Pharmaceuticals 120
Not applicableStudy completedNCT07073326
What this trial is testing

Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNormobaric Hypoxia
University of Trieste 16
Testing effectiveness (Phase 2)Looking for participantsNCT07459504
What this trial is testing

SMART Diets for MASLD

Who this might be right for
Metabolic-dysfunction Associated Steatotic Liver Disease
Michigan State University 102
Not applicableNot Yet RecruitingNCT07032311
What this trial is testing

Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk

Who this might be right for
Type 2 DiabetesLiver Disease
SIPPA Solutions INC 180
Not applicableNot Yet RecruitingNCT07781371
What this trial is testing

A Retrospective Real-World Cohort Study

Who this might be right for
ObesityType 2 Diabetes (T2D)Prediabetes+4 more
Novo Nordisk A/S 100,000
Not applicableLooking for participantsNCT07518784
What this trial is testing

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

Who this might be right for
MASLDMASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)NAFLD+1 more
University of California, San Diego 26
Not applicableNot Yet RecruitingNCT07775638
What this trial is testing

Detecting Liver Fibrosis in Patients At-risk

Who this might be right for
Fatty LiverNAFLD - Non-Alcoholic Fatty Liver DiseaseNash+4 more
Helse Stavanger HF 1,200
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Not applicableEnrolling By InvitationNCT07312136
What this trial is testing

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseCirrhosisAdvanced Fibrosis+6 more
Linkoeping University 317
Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Not applicableEnrolling By InvitationNCT06986447
What this trial is testing

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
HRI-MAIL-NIT 1,689
Not applicableLooking for participantsNCT07378072
What this trial is testing

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity

Who this might be right for
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Nantes University Hospital 72
Next Page
114